Mechanisms of Sleep-Wake Disruption During Hospitalization

Abstract

Sleep-wake disruption is a prevalent and clinically significant complication among hospitalized patients, impacting physical recovery, psychological well-being, and healthcare outcomes. This review synthesizes recent advances in the understanding of the underlying mechanisms of hospital-acquired sleep disturbances, with a focus on epidemiology, pathophysiology, risk factors, clinical manifestations, diagnostic challenges, and evidence-based management. Emphasis is placed on the interplay between environmental, medical, and neurobiological contributors to sleep-wake dysregulation, highlighting both established and emerging therapeutic strategies. Clinically relevant insights and guideline-driven recommendations are discussed to aid physicians in optimizing sleep health during hospitalization.

Introduction

Hospitalization frequently disrupts normal sleep-wake cycles, with up to 70% of inpatients experiencing significant sleep disturbances. These disruptions are associated with adverse outcomes, such as increased delirium risk, impaired immune function, prolonged recovery, and higher rates of hospital complications. For clinicians, understanding and addressing the multifactorial mechanisms underlying sleep-wake disruption is essential to improving patient outcomes and overall quality of care. This review aims to provide a comprehensive, evidence-based overview of the mechanisms of sleep-wake disruption during hospitalization, integrating current research, clinical guidelines, and practical management strategies.

Epidemiology / Disease Burden

Sleep disturbances are highly prevalent among hospitalized adults and children. Recent multicenter studies report that 40% to 70% of inpatients suffer from reduced total sleep time, sleep fragmentation, and poor sleep quality. The burden is especially high in intensive care units (ICUs), where polysomnographic studies reveal marked reductions in REM and slow-wave sleep. Hospital-acquired sleep disruption is independently associated with increased length of stay, higher rates of delirium and nosocomial infections, impaired wound healing, and long-term neurocognitive deficits. Vulnerable populations, such as the elderly, critically ill, and those with pre-existing sleep disorders, are disproportionately affected.

Pathophysiology

The pathophysiology of sleep-wake disruption during hospitalization is multifactorial, involving both exogenous and endogenous mechanisms. Environmental factors include excessive noise, frequent staff interruptions, bright artificial lighting, and lack of diurnal cues. Medical interventions, such as nocturnal vital sign checks, medication administration, and diagnostic procedures, further fragment sleep. Endogenously, acute illness triggers inflammatory cytokine release (e.g., IL-6, TNF-α) and activates the hypothalamic-pituitary-adrenal (HPA) axis, resulting in hypercortisolemia and altered melatonin secretion—both of which disrupt circadian rhythms. Additionally, pain, anxiety, and the direct effects of medications (e.g., corticosteroids, sedatives, beta-blockers) contribute to sleep fragmentation and reduced sleep efficiency.

Risk Factors

Several patient-specific and hospital-related factors elevate the risk of sleep-wake disruption. Patient-related risk factors include advanced age, pre-existing sleep disorders (such as insomnia and obstructive sleep apnea), cognitive impairment, psychiatric comorbidities, and polypharmacy. Hospital-related risk factors encompass admission to ICUs, exposure to round-the-clock lighting, frequent nocturnal care activities, and use of mechanical ventilation or non-invasive respiratory support. Severity of underlying illness and high acuity admissions further exacerbate sleep disturbances, particularly in the context of delirium-prone populations.

Clinical Features

Hospital-acquired sleep disruption manifests as difficulty initiating or maintaining sleep, frequent nighttime awakenings, reduced total sleep time, and non-restorative sleep. Daytime consequences include excessive somnolence, neurocognitive impairment, mood disturbances, and heightened delirium risk—especially among older adults and critically ill patients. Polysomnography and actigraphy studies in hospitalized populations consistently demonstrate reduced REM and slow-wave sleep, increased wake after sleep onset, and circadian rhythm misalignment, which may persist post-discharge and contribute to post-hospital syndrome.

Diagnosis

Diagnosis relies on clinical assessment, focused sleep history, and, when feasible, objective measurement via actigraphy or polysomnography. Key diagnostic challenges include distinguishing primary sleep disorders from hospital-induced disturbances and identifying reversible contributors, such as pain, anxiety, or medication effects. Screening tools such as the Richards-Campbell Sleep Questionnaire (RCSQ) and the Pittsburgh Sleep Quality Index (PSQI) are validated for use in hospitalized patients. Early identification and monitoring are crucial for timely intervention, particularly in high-risk groups.

Treatment & Management

Management is centered on non-pharmacological and pharmacological strategies tailored to individual risk profiles and underlying contributors. Environmental modifications—such as noise reduction protocols, dimmed lighting at night, clustering of care activities, and provision of earplugs and eye masks—are foundational. Cognitive-behavioral interventions, relaxation techniques, and sleep hygiene education are effective adjuncts. Pharmacologic therapy is reserved for refractory cases and may include short-term use of melatonin, low-dose trazodone, or other sedative-hypnotics, with caution regarding delirium and respiratory depression. Multidisciplinary collaboration among physicians, nurses, and allied health professionals is critical for sustained improvement.

Recent Advances / Emerging Therapies

Recent research has focused on circadian-friendly hospital design, dynamic lighting systems, and personalized sleep-promotion protocols. Wearable devices for continuous sleep monitoring and real-time feedback have shown promise in early detection of sleep disturbances. Pharmacogenomics and chronotherapeutics are emerging areas exploring individualized therapy based on circadian biology. Innovations in ICU sleep promotion include noise-canceling technology, scheduled quiet times, and incorporation of natural light to support circadian entrainment. Ongoing clinical trials are evaluating novel agents targeting neuroinflammatory pathways implicated in sleep-wake dysregulation.

Guideline Recommendations

Major guidelines, including those from the American Academy of Sleep Medicine (AASM) and Society of Critical Care Medicine (SCCM), recommend systematic assessment of sleep quality, minimization of nocturnal disruptions, and prioritization of non-pharmacologic interventions. Pharmacologic agents should be used judiciously, with careful risk-benefit evaluation, especially in older adults and those at risk for delirium. Interdisciplinary sleep teams and institutional protocols are advocated to standardize care and enhance sleep-wake regulation during hospitalization.

Conclusion

Sleep-wake disruption during hospitalization is a complex, multifactorial phenomenon with significant clinical and prognostic implications. A mechanistic understanding of environmental, medical, and neurobiological contributors is essential for effective prevention and treatment. Evidence-based strategies—encompassing environmental modifications, tailored pharmacotherapy, and multidisciplinary collaboration—are paramount. Ongoing research into circadian biology and emerging technologies holds promise for advancing sleep health in hospitalized patients and improving overall patient care outcomes.